This double-blind trial randomized 165 healthy term infants 25-45 days old to receive Control formula ( n = 54 ) , formula containing high sn-2 palmitate ( sn-2 ; n = 56 ) , or formula containing high sn-2 palmitate plus 3 g/L OF ( sn-2 + OF ; n = 55 ) .